FLH Partner Brian J. Malkin Speaks at ACI Maximizing Pharmaceutical Patent Life Cycles Conference in New York on October 5, 2011 in New York

Frommer Lawrence & Haug LLP Partner Brian J. Malkin will speak on a hot issue concerning 180-day exclusivity for first Paragraph IV applicant generics, “Exclusivities and Forfeitures: New Developments, Controversies and Concerns” at the American Conference Institute’s 12th Annual Maximizing Pharmaceutical Patent Life Cycles Conference New York City, held from October 4-5, 2011. Now that FDA has issued a number of forfeiture rulings, some of which have been successfully challenged in court, FDA has started issuing decisions without offering an opportunity for public comments. Come and find out the latest developments in this area and how it may affect your pharmaceutical product development.

FDA Lawyers Blog readers may obtain a $200 discount by mentioning FDA Lawyers Blog and using the code “FDA 200”. You may register for the conference here.